Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Prostatectomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24 Prostatic Hyperplasia 2 Urinary Incontinence 1 Recurrence 1 Lymphocele 1 Disease 1 Adenocarcinoma 1

Interventions

Magnetic Resonance Spectroscopy 6 Blood Specimen Collection 6 Surveys and Questionnaires 5 Mammography 5 Colonoscopy 5 Magnetic Resonance Imaging 4 Dexamethasone 4 Cyclophosphamide 4 Biopsy, Fine-Needle 4 Tomography, X-Ray Computed 3 Prednisone 3 Positron Emission Tomography Computed Tomography 3 Melphalan 3 Liquid Biopsy 3 Lenalidomide 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 Biopsy 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 Urination 2 Surgical Procedures, Operative 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Injections 2 Immunohistochemistry 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07054346 2025-12-01

LUTACT

University of California, San Francisco

Phase 1 Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡